Table 1.
A summary of extracorporeal devices for treating sepsis.
| Product Name | Principle | Company | Country | Targets of removal |
|---|---|---|---|---|
| oXiris® | Adsorption | Baxter Int. Inc. | USA | Endotoxins, cytokines, uremic toxin |
| Toraymyxin™ | Toray Industries | Japan | Gram-negative bacteria, endotoxin | |
| Alteco® LPS Adsorber | Alteco Medical AB | Sweden | Endotoxin | |
| Seraph® | ExThera Medical | USA | Bacteria (MRSA, E.coli, ESBL-K. pneumoniae, VRE, etc.) | |
| Cytosorb® | CytoSorbents | USA | Cytokines | |
| Under development | BOA Biomedical Inc.* | USA | A broad range of pathogens | |
| Under development | Magnetic particle separation | hemotune* | Switzerland | Endotoxin, cytokines, drugs, heavy metals |
* Startup company